Related Experiment Video
Updated: May 7, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Bacterial meningitis: new therapeutic approaches
Roland Nau1, Marija Djukic, Annette Spreer
1Department of Geriatrics, Evangelisches Krankenhaus Göttingen-Weende, An der Lutter 24, 37075 Göttingen, Germany.
Expert Review of Anti-Infective Therapy
|October 1, 2013
Summary
Bacterial meningitis requires prompt antibiotic treatment. New strategies, like non-lytic bactericidal antibiotics and vaccination, are crucial due to rising antimicrobial resistance.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Bacterial meningitis presents significant mortality and morbidity risks.
- Effective antibiotic therapy initiation is critical for patient outcomes.
- Increasing antimicrobial resistance in meningitis pathogens necessitates optimized empirical treatment.
Purpose of the Study:
- To explore optimal empirical antibiotic regimens for bacterial meningitis.
- To evaluate the potential of bactericidal, non-lytic antibiotics.
- To assess the evolving role of adjunctive therapies like corticosteroids.
Main Methods:
- Literature review on bacterial meningitis treatment strategies.
- Analysis of antibiotic resistance trends in meningitis pathogens.
- Evaluation of drug properties affecting cerebrospinal fluid penetration.
Main Results:
- Emerging antibiotic resistance impacts treatment efficacy.
- Non-lytic bactericidal antibiotics may offer a therapeutic advantage.
- Corticosteroid use may decrease with rising resistance due to impaired antibiotic penetration.
Conclusions:
- Optimizing initial empirical antibiotic choice is vital for bacterial meningitis.
- Vaccination remains the most effective method to reduce disease burden.
- Future therapeutic strategies must address increasing antimicrobial resistance.
Related Concept Videos
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
01:26Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...